UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention

27th April 2026 Uncategorised 0

Clesrovimab is first monoclonal antibody offering a single fixed dose for infants

More: UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention
Source: News